Latest News

Piper

TILT Biotherapeutics was highlighted as one of the key companies developing oncolytic viruses in an interesting report entiteled ” A New Wave of Cancer Therapies: Local Tumor Immuno-Rx Drives Distant Effects”, published by Piper Jaffray & Co.

Latest News

Upcoming Events

Please contact our business development team to meet us at the following events:

7-9th December 2022
Geneva, Switzerland
20-22nd March 2023
Basel, Switzerland
15–16th May 2023
Dublin, Ireland
5-8th June 2023
Boston (MA), USA
2-6th June 2023
Chicago (IL), USA